Vanguard Personalized Indexing Management
MYGN icon

Vanguard Personalized Indexing Management’s Myriad Genetics MYGN Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$89.7K Sell
15,717
-4,409
-22% -$20K ﹤0.01% 2067
2026
Q1 		$90.6K Buy
+20,126
New +$105K ﹤0.01% 1966

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Personalized Indexing Management's MYGN Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its Myriad Genetics (MYGN) stake by 22% in Q2 2026, selling an estimated $20K and leaving 15,717 shares worth $89.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2067.

Vanguard Personalized Indexing Management first reported a position in MYGN in Q1 2026 and has held it in 2 quarters since. The position peaked at $90.6K in Q1 2026. 197 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • Vanguard Personalized Indexing Management held 15,717 shares of Myriad Genetics worth $89.7K as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 4,409 Myriad Genetics shares in Q2 2026, an estimated $20K.
  • Myriad Genetics made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #2067 holding.
  • Vanguard Personalized Indexing Management first reported a position in Myriad Genetics in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Personalized Indexing Management's Myriad Genetics position peaked at $90.6K in Q1 2026.
  • 197 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.